Literature DB >> 12919639

[Patients of severe acute respiratory syndrome with hypoxemia treated by anisodamine].

Guo-dong Yang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12919639

Source DB:  PubMed          Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue        ISSN： 1003-0603


× No keyword cloud information.
  3 in total

1.  Network Pharmacology Integrated Molecular Docking Reveals the Mechanism of Anisodamine Hydrobromide Injection against Novel Coronavirus Pneumonia.

Authors:  Jinsong Su; Zixuan Liu; Chuan Liu; Xuanhao Li; Yi Wang; Jing Zhao; Qingjiang Wu; Shichao Zheng; Yi Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-08-05       Impact factor: 2.629

2.  Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease.

Authors:  Wei Wei; Ni Kong; Meng-Zhen Liu; Ting Han; Jun-Feng Xu; Chong Liu
Journal:  Biochem Biophys Res Commun       Date:  2022-05-13       Impact factor: 3.322

3.  Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19.

Authors:  Zhen Qin; Kefa Xiang; Ding-Feng Su; Yang Sun; Xia Liu
Journal:  Front Immunol       Date:  2021-02-08       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.